跳至主要内容
临床试验/IRCT20120415009472N26
IRCT20120415009472N26招募中2 期

The effect of Portulaca Oleracea supplement on inflammatory markers, antioxidant status and quality of life in patients with ulcerative colitis

Iran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • The patient has expressed his / her consent to participate in the study.
  • Age 18 years and older
  • Diagnosis of ulcerative colitis by a gastroenterologist and determination of the severity of the disease in mild to moderate stage
  • Taking glucocorticosteroids
  • BMI higher than 18.5 and less than 30
  • No pregnancy and lactation
  • Do not take supplements (antioxidants, omega 3, etc.) in the last quarter (except for routine supplements prescribed for ulcerative colitis)
  • No decision to become pregnant during the intervention
  • Lack of other diseases and obvious intestinal disorders, known autoimmune diseases, cancer, inflammatory and infectious diseases
  • No edema due to heart and kidney disease

排除标准

  • Reluctance to continue cooperation
  • No supplementation (patient acceptance and adaptation level is less than 80%).
  • Recurrence of the disease in a way that leads to hospitalization of the patient
  • Changing the type and dose of the patient's drugs during the intervention
  • Sudden onset of an acute illness (bacterial and viral infections, burns, heart attack, etc.)
  • Taking anticoagulants such as warfarin or heparin
  • Taking antihistamines and NSAIDs (ibuprofen, aspirin, diclofenac)
  • Taking contraceptives
  • During menstruation women

研究者

相似试验